
Dermatologicals in Algeria
Description
Dermatologicals in Algeria
The incidence of common dermatological problems in Algeria is rising in 2024, driven by favourable demographic trends such as a growing older population and relatively high, though gradually declining, birth rates. These factors are further supported by increasing consumer awareness and continuous product developments. The knowledge and understanding of dermatological products and their effectiveness are improving, largely due to the active efforts of healthcare professionals, including doctors...
Euromonitor International's Dermatologicals in Algeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
20 Pages
- Dermatologicals in Algeria
- Euromonitor International
- September 2024
- List Of Contents And Tables
- DERMATOLOGICALS IN ALGERIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Professional recommendations increase awareness of dermatological efficacy
- Paediatric dermatologicals lead growth
- Saidal Algerie SpA retains leadership
- PROSPECTS AND OPPORTUNITIES
- Changing consumer habits and new product developments to drive growth
- Economic challenges may slow growth in dermatologicals
- Increased product diversity expected with greater investment
- CATEGORY DATA
- Table 1 Sales of Dermatologicals by Category: Value 2019-2024
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Dermatologicals: % Value 2020-2024
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2021-2024
- Table 5 Forecast Sales of Dermatologicals by Category: Value 2024-2029
- Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN ALGERIA
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.